Japan’s manufacturing-DX specialist deepens SaaS partnership in pharma MES and advances AI-enabled finance and governance for multinationals

Business Engineering Corporation (B-EN-G) has announced a strategic equity investment in BatchLine Co., Ltd., a Thailand-based provider of cloud MES for pharmaceutical manufacturing, alongside preparations for its “GLASIAOUS Next 2025: Next-generation Management Transformation” online forum. Together, the moves underline B-EN-G’s ambition to offer an integrated digital stack for global manufacturers, from shop-floor execution to AI-enabled group finance.
B-EN-G will invest up to JPY 100 million in BatchLine, following a partnership signed in January 2025 and the start of domestic provision of the BatchLine MES in March. The solution targets urgent needs in the pharma industry to digitise master batch records (MBR) and electronic batch records (EBR) in line with GMP requirements and data-integrity regulations. Pilot projects in Japan, particularly among small and mid-sized pharma companies, have confirmed strong demand for an affordable SaaS-type MES.
According to the announcement, the capital participation has three goals: accelerating joint expansion in global markets, strengthening product development and service delivery by combining B-EN-G’s pharma domain knowledge with BatchLine’s SaaS expertise, and deepening the long-term strategic partnership between the two companies. The partners aim to become leaders in digital solutions that support quality, compliance and productivity in pharma manufacturing worldwide.

Toyo Business Engineering (Thailand)’s HQ Being Blessed by Buddhist Monks
On the finance and management side, B-EN-G is convening GLASIAOUS Next 2025, an online forum co-organized with The Sankei Shimbun and the GLASIAOUS Consortium, under the theme “Next-generation management transformation – strategy and practice, strengthening international competitiveness through AI utilization.” The event brings together experts to discuss how AI can transform group governance, IFRS/ESG reporting and cross-border management, with B-EN-G’s GLASIAOUS cloud ERP positioned as a backbone for multinational consolidation and control.
By combining an equity stake in a high-growth pharma MES provider with thought leadership around AI-driven global management, B-EN-G is signaling a dual strategy: deepening vertical solutions on the factory floor while widening its role in the digital transformation of corporate headquarters and international group management.
For more information, please visit their website at: https://www.b-en-g.co.jp/en/about/
0 COMMENTS